Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Atrioventricular block second degree? 34 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Atrioventricular block second degree have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.1% of all adverse event reports for ARIPIPRAZOLE.

34
Reports of Atrioventricular block second degree with ARIPIPRAZOLE
0.1%
of all ARIPIPRAZOLE reports
0
Deaths
32
Hospitalizations

How Dangerous Is Atrioventricular block second degree From ARIPIPRAZOLE?

Of the 34 reports, 32 (94.1%) required hospitalization, and 15 (44.1%) were considered life-threatening.

Is Atrioventricular block second degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Atrioventricular block second degree?

FINGOLIMOD (167) DILTIAZEM (76) BISOPROLOL (73) METOPROLOL (67) OMEPRAZOLE (64) AMLODIPINE (58) ASPIRIN (55) LACOSAMIDE (55) AMIODARONE (49) FLUOXETINE (44)

Which ARIPIPRAZOLE Alternatives Have Lower Atrioventricular block second degree Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Atrioventricular block second degree Reports All Drugs Causing Atrioventricular block second degree ARIPIPRAZOLE Demographics